Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Li-Fraumeni Syndrome 1Glioma 1Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diffusion Magnetic Resonance Imaging × 90 days × Clear all
NCT03176836 2026-04-29

Li-Fraumeni Syndrome Imaging Study

The Hospital for Sick Children

Phase NA Enrolling by invitation
30 enrolled

Li-Fraumeni Syndrome

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting
20 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡